Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients

Annals of Clinical Microbiology and Antimicrobials

Volumn 12, Issue 1, 2013, Pages

  Seck, Abdoulaye ^a   Burucoa, Christophe ^b   Dia, Daouda ^c   Mbengue, Mouhamadou ^c   Onambele, Manuella ^a   Raymond, Josette ^d   Breurec, Sebastien ^a  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b UNIVERSITÉ DE POITIERS   (France)

^c Centre Hospitalier Universitaire Dakar   (Senegal)

^d INSTITUT PASTEUR   (France)

Author keywords

Antibiotic resistance; Clarithromycin; Helicobacter pylori; Levofloxacin; Senegal

Indexed keywords

AMOXICILLIN; CEFSULODIN; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; QUINOLONE; RNA 23S; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; SENEGAL; UPPER ABDOMINAL PAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; CLARITHROMYCIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; OFLOXACIN; RNA, RIBOSOMAL, 23S; SENEGAL; TETRACYCLINE; YOUNG ADULT;

EID: 84871945635     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-12-3     Document Type: Article

References (27)

1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131. 10.1056/NEJM199110173251603, 1891020.
2. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 2012, 61:646-664. 10.1136/gutjnl-2012-302084, 22491499.
3. Megraud F. Helicobacter pylori and antibiotic resistance. Gut 2007, 56:1502. 10.1136/gut.2007.132514, 2095668, 17938430.
4. Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France. Antimicrob Agents Chemother 2012, 56:550-551. 10.1128/AAC.05243-11, 3256052, 22064536.
5. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, Pedrazzoli J. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003, 3:20. 10.1186/1471-230X-3-20, 194586, 12911839.
6. Nahar S, Mukhopadhyay AK, Khan R, Ahmad MM, Datta S, Chattopadhyay S, Dhar SC, Sarker SA, Engstrand L, Berg DE, Nair GB, Rahman M. Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol 2004, 42:4856-4858. 10.1128/JCM.42.10.4856-4858.2004, 522322, 15472362.
7. Aboderin OA, Abdu AR, Odetoyin B, Okeke IN, Lawal OO, Ndububa DA, Agbakwuru AE, Lamikanra A. Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria. Afr Health Sci 2007, 7:143-147. 2269713, 18052867.
8. Seck A, Mbengue M, Gassama-Sow A, Diouf L, Ka MM, Boye CS. Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal. J Infect Dev Ctries 2009, 3:137-140.
9. Ndip RN, Malange Takang AE, Ojongokpoko JE, Luma HN, Malongue A, Akoachere JF, Ndip LM, MacMillan M, Weaver LT. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Trop Med Int Health 2008, 13:848-854. 10.1111/j.1365-3156.2008.02062.x, 18384477.
10. Price AB. Classification of gastritis-yesterday, today and tomorrow. Verhandlungen der Deutschen Gesellschaft fur Pathologie 1999, 83:52-55.
11. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255. 10.1136/gut.47.2.251, 1728018, 10896917.
12. Ben Mansour K, Burucoa C, Zribi M, Masmoudi A, Karoui S, Kallel L, Chouaib S, Matri S, Fekih M, Zarrouk S, Labbene M, Boubaker J, Cheikh I, Hriz MB, Siala N, Ayadi A, Filali A, Mami NB, Najjar T, Maherzi A, Sfar MT, Fendri C. Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob 2010, 9:22. 10.1186/1476-0711-9-22, 2928169, 20707901.
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twentieth informational supplement 2012, M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute, CLSI document, Clinical and Laboratory Standards Institute.
14. European Committee on Antimicrobial Susceptibility Testing EUCAST Disk diffusion manual 2012 http://www.eucast.org/eucast_susceptibility_testing/disk_diffusion_methodology., European Committee on Antimicrobial Susceptibility Testing.
15. Glocker E, Stueger HP, Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother 2007, 51:346-349. 10.1128/AAC.00614-06, 1797685, 17043117.
16. Hung KH, Sheu BS, Chang WL, Wu HM, Liu CC, Wu JJ. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter 2009, 14:61-65. 10.1111/j.1523-5378.2009.00655.x, 19191898.
17. Kim JM, Kim JS, Kim N, Jung HC, Song IS. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 2005, 56:965-967. 10.1093/jac/dki334, 16159928.
18. Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003, 47:3942-3944. 10.1128/AAC.47.12.3942-3944.2003, 296230, 14638505.
19. Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 2007, 29:389-396. 10.1016/j.ijantimicag.2006.11.007, 17303392.
20. Cuadrado-Lavin A, Salcines-Caviedes JR, Carrascosa MF, Mellado P, Monteagudo I, Llorca J, Cobo M, Campos MR, Ayestaran B, Fernandez-Pousa A, Gonzalez-Colominas E. Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. J Antimicrob Chemother 2012, 67:170-173. 10.1093/jac/dkr410, 21965436.
21. Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther 2010, 8:59-70. 10.1586/eri.09.113, 20014902.
22. Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries 2007, 1:263-268.
23. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, Ierardi E, Zullo A. Worldwide Helicobacter pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010, 19:409-414.
24. Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW. Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J Clin Microbiol 2004, 42:4832-4834. 10.1128/JCM.42.10.4832-4834.2004, 522302, 15472354.
25. Asrat D, Kassa E, Mengistu Y, Nilsson I, Wadstrom T. Antimicrobial susceptibility pattern of Helicobacter pylori strains isolated from adult dyspeptic patients in Tikur Anbassa University Hospital, Addis Ababa, Ethiopia. Ethiop Med J 2004, 42:79-85.
26. Gisbert JP. Rescue Therapy for Helicobacter pylori Infection 2012. Gastroenterol Res Pract 2012, in press.
27. Liou JM, Chen CC, Chen MJ, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 2012, in press.